Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-20

Clinical Trial Update: A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating milnacipran's effects on pain processing and functional MRI in fibromyalgia patients has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: University of Michigan | Conditions: Fibromyalgia | Phase 4 | Status: COMPLETED | Results posted: 2015-02-20